相关实验视频
Updated: Sep 13, 2025

05:37
An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
2.2K
强有力的COVID-19死亡风险评估:国家COVID队列协作协作的两步算法的验证
Bingnan Li1, Yuan Ke1, Xianyan Chen2
1Department of Statistics, University of Georgia, Georgia, USA.
The Journal of infectious diseases
|July 27, 2025
概括
一个新的两步算法有效地利用数百万患者的临床数据预测COVID-19死亡风险. 这种经过验证的工具通过适应不断变化的死亡率趋势,包括在Omicron激增期间,来帮助流行病管理.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 医疗信息学 医疗信息学
背景情况:
- 由于COVID-19的流行,人们需要强大的工具来评估死亡风险.
- 现有的临床指标需要一个验证的,可扩展的算法来分层患者的风险.
- 国家COVID队列协作 (N3C) 为开发和验证这些工具提供了一个大规模的数据集.
研究的目的:
- 引入和验证一种新的两步算法,用于预测COVID-19死亡风险.
- 评估算法在不同患者群体和临床环境中的性能.
- 评估算法的适应性,以适应不断演变的SARS-CoV-2变种和死亡率趋势.
主要方法:
- 使用常规临床指标开发和验证双步算法.
- 利用来自国家COVID队列协作 (N3C) 的700多万COVID-19病例的大数据集.
- 使用C统计对240万个子集和768,957个完整记录的性能评估,包括归算数据集的分析.
主要成果:
- 两步算法表现出强大的预测性能,C统计超过0.85.
- 该算法在多样化的机构队列和多样化的临床数据完整性中显示出强度和适应性.
- 在Omicron变异激增期间保持了有效的表现,表明适应不断变化的死亡率趋势的适应性.
结论:
- 经过验证的两步算法是评估COVID-19死亡风险的可扩展和可靠工具.
- 数据驱动的方法对于有效的流行病管理和公共卫生干预至关重要.
- 该算法的跨多种数据集的性能突出显示了其在现实世界临床环境中的实用性.
相关概念视频
Actuarial Approach
137
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
137
Relative Risk
348
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
348
Comparing the Survival Analysis of Two or More Groups
289
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
289
Assessment of blood pressure in brachial artery(two-step method)
912
Measuring blood pressure is a fundamental skill in healthcare that aids in diagnosing and monitoring hypertension and other cardiovascular conditions. An aneroid sphygmomanometer, commonly used in clinical settings, offers a manual and precise method for blood pressure measurement. The technique for using this instrument involves specific steps that must be carefully executed to ensure accuracy. The following detailed description outlines a two-step technique for assessing blood pressure using...
912
Assumptions of Survival Analysis
198
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
198
Cancer Survival Analysis
456
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
456

